BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37021767)

  • 1. Creation and preclinical evaluation of a novel mussel-inspired, biomimetic, bioactive bone graft scaffold: direct comparison with Infuse bone graft using a rat model of spinal fusion.
    Cottrill E; Pennington Z; Wolf MT; Dirckx N; Ehresman J; Perdomo-Pantoja A; Rajkovic C; Lin J; Maestas DR; Mageau A; Lambrechts D; Stewart V; Sciubba DM; Theodore N; Elisseeff JH; Witham T
    J Neurosurg Spine; 2023 Jul; 39(1):113-121. PubMed ID: 37021767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Healos/bone marrow to INFUSE(rhBMP-2/ACS) with a collagen-ceramic sponge bulking agent as graft substitutes for lumbar spine fusion.
    Kraiwattanapong C; Boden SD; Louis-Ugbo J; Attallah E; Barnes B; Hutton WC
    Spine (Phila Pa 1976); 2005 May; 30(9):1001-7; discussion 1007. PubMed ID: 15864149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simple carrier matrix modifications can enhance delivery of recombinant human bone morphogenetic protein-2 for posterolateral spine fusion.
    Akamaru T; Suh D; Boden SD; Kim HS; Minamide A; Louis-Ugbo J
    Spine (Phila Pa 1976); 2003 Mar; 28(5):429-34. PubMed ID: 12616152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early-term and mid-term histologic events during single-level posterolateral intertransverse process fusion with rhBMP-2/collagen carrier and a ceramic bulking agent in a nonhuman primate model: implications for bone graft preparation.
    Khan SN; Toth JM; Gupta K; Glassman SD; Gupta MC
    J Spinal Disord Tech; 2014 Jun; 27(4):212-9. PubMed ID: 23073151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiographic, biomechanical, and histological evaluation of rhBMP-2 in a 3-level intertransverse process spine fusion: an ovine study.
    Toth JM; Wang M; Lawson J; Badura JM; DuBose KB
    J Neurosurg Spine; 2016 Dec; 25(6):733-739. PubMed ID: 27367941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The local cytokine and growth factor response to recombinant human bone morphogenetic protein-2 (rhBMP-2) after spinal fusion.
    Koerner JD; Markova DZ; Schroeder GD; Calio BP; Shah A; Brooks CW; Vaccaro AR; Anderson DG; Kepler CK
    Spine J; 2018 Aug; 18(8):1424-1433. PubMed ID: 29550606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate.
    Boden SD; Martin GJ; Morone MA; Ugbo JL; Moskovitz PA
    Spine (Phila Pa 1976); 1999 Jun; 24(12):1179-85. PubMed ID: 10382242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental spinal fusion with recombinant human bone morphogenetic protein-2 delivered by a synthetic polymer and beta-tricalcium phosphate in a rabbit model.
    Namikawa T; Terai H; Suzuki E; Hoshino M; Toyoda H; Nakamura H; Miyamoto S; Takahashi N; Ninomiya T; Takaoka K
    Spine (Phila Pa 1976); 2005 Aug; 30(15):1717-22. PubMed ID: 16094272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex-based Difference in Response to Recombinant Human Bone Morphogenetic Protein-2 in a Rat Posterolateral Fusion Model.
    Foley JP; Fred EJ; Minardi S; Yamaguchi JT; Greene AC; Furman AA; Lyons JG; Paul JT; Nandurkar TS; Blank KR; Havey RM; Muriuki M; Patwardhan AG; Hsu WK; Stock SR; Hsu EL
    Spine (Phila Pa 1976); 2022 Dec; 47(23):1627-1636. PubMed ID: 35943241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanocomposite therapy as a more efficacious and less inflammatory alternative to bone morphogenetic protein-2 in a rodent arthrodesis model.
    Hsu WK; Polavarapu M; Riaz R; Roc GC; Stock SR; Glicksman ZS; Ghodasra JH; Hsu EL
    J Orthop Res; 2011 Dec; 29(12):1812-9. PubMed ID: 21590717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower dose of rhBMP-2 achieves spine fusion when combined with an osteoconductive bulking agent in non-human primates.
    Barnes B; Boden SD; Louis-Ugbo J; Tomak PR; Park JS; Park MS; Minamide A
    Spine (Phila Pa 1976); 2005 May; 30(10):1127-33. PubMed ID: 15897825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is lumbar facet fusion biomechanically equivalent to lumbar posterolateral onlay fusion?
    Toth JM; Foley KT; Wang M; Seim HB; Simon Turner A
    J Neurosurg Spine; 2017 May; 26(5):586-593. PubMed ID: 28156207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental spinal fusion with use of recombinant human bone morphogenetic protein 2.
    Itoh H; Ebara S; Kamimura M; Tateiwa Y; Kinoshita T; Yuzawa Y; Takaoka K
    Spine (Phila Pa 1976); 1999 Jul; 24(14):1402-5. PubMed ID: 10423783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental spinal fusion using sintered bovine bone coated with type I collagen and recombinant human bone morphogenetic protein-2.
    Minamide A; Tamaki T; Kawakami M; Hashizume H; Yoshida M; Sakata R
    Spine (Phila Pa 1976); 1999 Sep; 24(18):1863-70; discussion 1871-2. PubMed ID: 10515009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of platelet-rich plasma and bone marrow on murine posterolateral lumbar spine arthrodesis with bone morphogenetic protein.
    Rao RD; Gourab K; Bagaria VB; Shidham VB; Metkar U; Cooley BC
    J Bone Joint Surg Am; 2009 May; 91(5):1199-206. PubMed ID: 19411469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of recombinant human bone morphogenetic protein-2 using a compression-resistant matrix in posterolateral spine fusion in the rabbit and in the non-human primate.
    Suh DY; Boden SD; Louis-Ugbo J; Mayr M; Murakami H; Kim HS; Minamide A; Hutton WC
    Spine (Phila Pa 1976); 2002 Feb; 27(4):353-60. PubMed ID: 11840099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of recombinant human bone morphogenetic protein 2 (rhBMP-2) to promote spinal fusion in a nonhuman primate anterior interbody fusion model.
    Hecht BP; Fischgrund JS; Herkowitz HN; Penman L; Toth JM; Shirkhoda A
    Spine (Phila Pa 1976); 1999 Apr; 24(7):629-36. PubMed ID: 10209790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vertical Bone Augmentation Using Deproteinized Bovine Bone Mineral, Absorbable Collagen Sponge, and Recombinant Human Bone Morphogenetic Protein-2: An In Vivo Study in Rabbits.
    Kim YJ; de Molon RS; Horiguti FR; Contador GP; Coelho MA; Mascarenhas VI; de Souza Faloni AP; Cirelli JA; Sendyk WR
    Int J Oral Maxillofac Implants; 2018; 33(3):512–522. PubMed ID: 29543927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. rhBMP-2 enhancement of posterolateral spinal fusion in a rabbit model in the presence of concurrently administered doxorubicin.
    Singh K; Smucker JD; Ugbo JL; Tortolani PJ; Tsai L; Fei Q; Kuh S; Rumi M; Heller JG; Boden SD; Yoon ST
    Spine J; 2007; 7(3):326-31. PubMed ID: 17482116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of vancomycin powder on bone healing in a rat spinal rhBMP-2 model.
    Mendoza MC; Sonn KA; Kannan AS; Bellary SS; Mitchell SM; Singh G; Park C; Yun C; Stock SR; Hsu EL; Hsu WK
    J Neurosurg Spine; 2016 Aug; 25(2):147-53. PubMed ID: 27035510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.